EDGAR Filing Documents for 0001144204-17-047548

Form 8-K - Current report:

SEC Accession No. 0001144204-17-047548

Filing Date

2017-09-12

Accepted

2017-09-12 07:05:23

Documents

Period of Report

2017-09-11

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	v474946_8k.htm	8-K	39662
2	EXHIBIT 3.1	v474946_ex3-1.htm	EX-3.1	98268
3	EXHIBIT 4.1	v474946_ex4-1.htm	EX-4.1	108574
4	EXHIBIT 10.1	v474946_ex10-1.htm	EX-10.1	174981
5	EXHIBIT 99.1	v474946_ex99-1.htm	EX-99.1	10955
6	GRAPHIC	v474946_ex3-1img1.jpg	GRAPHIC	22311
7	GRAPHIC	image_001.jpg	GRAPHIC	5595
	Complete submission text file	0001144204-17-047548.txt		472967

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850

Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800

Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)